|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lobo N, Afferi L, Moschini M, Mostafid H,
Porten S, Psutka SP, Gupta S, Smith AB, Williams SB and Lotan Y:
Epidemiology, screening, and prevention of bladder cancer. Eur Urol
Oncol. 5:628–639. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng RS, Chen R, Han BF, Wang SM, Li L,
Sun KX, Zeng HM, Wei WW and He J: Cancer incidence and mortality in
China, 2022. Zhonghua Zhong Liu Za Zhi. 46:221–231. 2024.(In
Chinese). PubMed/NCBI
|
|
4
|
Li HZ, Zheng RS, Du LB, Zhang SW, Zhu C,
Wei WW and He J: Bladder cancer incidence, mortality and temporal
trends in China. Zhonghua Zhong Liu Za Zhi. 43:293–298. 2021.(In
Chinese). PubMed/NCBI
|
|
5
|
Miyata Y, Matsuo T, Ohba K, Mitsunari K,
Mukae Y, Otsubo A, Harada J, Matsuda T, Kondo T and Sakai H:
Present status, limitations and future directions of treatment
strategies using fucoidan-based therapies in bladder cancer.
Cancers (Basel). 12:37762020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abdelbaset AE, Abushahba MFN and Igarashi
M: Toxoplasma gondii in humans and animals in Japan: An
epidemiological overview. Parasitol Int. 87:1025332022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hill DE, Chirukandoth S and Dubey JP:
Biology and epidemiology of Toxoplasma gondii in man and animals.
Animal Health Res Rev. 6:41–61. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Uddin A, Hossain D, Ahsan MI, Atikuzzaman
M and Karim MR: Review on diagnosis and molecular characterization
of Toxoplasma gondii in humans and animals. Trop Biomed.
38:511–539. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Milne G, Webster JP and Walker M:
Toxoplasma gondii: AnUnderestimated threat? Trends Parasitol.
36:959–969. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dubey JP, Murata FHA, Cerqueira-Cézar CK,
Kwok OCH and Villena I: Congenital toxoplasmosis in humans: An
update of worldwide rate of congenital infections. Parasitology.
148:1406–1416. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Halonen SK and Weiss LM: Toxoplasmosis.
Handb Clin Neurol. 114:125–145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Halici-Ozturk F, Yakut K, Öcal FD, Erol A,
Gökay S, Çağlar AT, Engin-Üstün Y and Ozgu-Erdinc AS:
Seroprevalence of Toxoplasma gondii infections in Syrian pregnant
refugee women in Turkey. Eur J Obstet Gynecol Reprod Biol.
256:91–94. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Molan A, Nosaka K, Hunter M and Wang W:
Global status of Toxoplasma gondii infection: Systematic review and
prevalence snapshots. Trop Biomed. 36:898–925. 2019.PubMed/NCBI
|
|
14
|
Rahmanian V, Rahmanian K, Jahromi AS and
Bokaie S: Seroprevalence of toxoplasma gondii infection: An
umbrella review of updated systematic reviews and meta-analyses. J
Family Med Prim Care. 9:3848–3855. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abdollahi A, Razavian I, Razavian E,
Ghodsian S, Almukhtar M, Marhoommirzabak E, Sartip B, Parsa H and
Rostami A: Toxoplasma gondii infection/exposure and the risk of
brain tumors: A systematic review and meta-analysis. Cancer
Epidemiol. 77:1021192022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Anvari D, Sharif M, Sarvi S, Aghayan SA,
Gholami S, Pagheh AS, Hosseini SA, Saberi R, Chegeni TN,
Hosseininejad Z and Daryani A: Seroprevalence of Toxoplasma gondii
infection in cancer patients: A systematic review and
meta-analysis. Microb Pathog. 129:30–42. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cong W, Liu GH, Meng QF, Dong W, Qin SY,
Zhang FK, Zhang XY, Wang XY, Qian AD and Zhu XQ: Toxoplasma gondii
infection in cancer patients: Prevalence, risk factors, genotypes
and association with clinical diagnosis. Cancer Lett. 359:307–313.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu Y, Guo D, Qu T, Zhao S, Xu C, Wang L,
Wang Z, Fu H, Zhang X and Zhou N: Increased risk of Toxoplasma
gondii infection in patients with colorectal cancer in Eastern
China: Seroprevalence, risk factors, and a case-control study.
Biomed Res Int. 2020:25394822020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou N, Zhang XY, Li YX, Wang L, Wang LL
and Cong W: Seroprevalence and risk factors of Toxoplasma gondii
infection in oral cancer patients in China: A case-control
prospective study. Epidemiol Infect. 146:1891–1895. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zúñiga-Contreras M, Noemi-Hauck I,
Valenzuela-Cortés R, Barraza-Olivares M and Santolaya-de-Pablo ME:
Toxoplasma gondii IgG seroprevalence in children with cancer from
National Children's Antineoplastic Drug Program network in the
Metropolitan Region, Chile: A multicenter study. Rev Chilena
Infectol. 38:212–217. 2021.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ye H, Zhou X, Zhu B, Xiong T, Huang W, He
F, Li H, Chen L, Tang L and Ren Z: Toxoplasma gondii suppresses
proliferation and migration of breast cancer cells by regulating
their transcriptome. Cancer Cell Int. 24:1442024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ong CY, Abdalkareem EA and Khoo BY:
Functional roles of cytokines in infectious disease associated
colorectal carcinogenesis. Mol Biol Rep. 49:1529–1535. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lotfalizadeh N, Sadr S, Morovati S,
Lotfalizadeh M, Hajjafari A and Borji H: A potential cure for
tumor-associated immunosuppression by Toxoplasma gondii. Cancer Rep
(Hoboken). 7:e19632024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hosseini SA, Sharif M, Sarvi S, Janbabai
G, Keihanian S, Abediankenari S, Gholami S, Amouei A, Javidnia J,
Saberi R, et al: Toxoplasmosis among cancer patients undergoing
chemotherapy: A population study based on the serological,
molecular and epidemiological aspects. Trans R Soc Trop Med Hyg.
115:677–686. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Costa W, Barbosa I, Prado D, Domann N and
Rezende HHA: A systematic review of Toxoplasma gondii genotypes in
Gallus gallus domesticus worldwide: The focus is Brazil. Transbound
Emerg Dis. 69:2440–2450. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang L, He LY, Meng DD, Chen ZW, Wen H,
Fang GS, Luo QL, Huang KQ and Shen JL: Seroprevalence and genetic
characterization of Toxoplasma gondii in cancer patients in Anhui
Province, Eastern China. Parasit Vectors. 8:1622015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen H, Yang W, Xue X, Li Y, Jin Z and Ji
Z: Integrated analysis revealed an inflammatory cancer-associated
fibroblast-based subtypes with promising implications in predicting
the prognosis and immunotherapeutic response of bladder cancer
patients. Int J Mol Sci. 23:159702022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Lai BS, Juhas M and Zhang Y:
Toxoplasma gondii secretory proteins and their role in invasion and
pathogenesis. Microbiol Res. 227:1262932019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu LQ, Yao LJ, Jiang D, Zhou LJ, Chen M,
Liao WZ, Zou WH and Peng H: A uracil auxotroph Toxoplasma gondii
exerting immunomodulation to inhibit breast cancer growth and
metastasis. Parasit Vectors. 14:6012021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu S, Lu J, Lin Z, Abuzeid AMI, Chen X,
Zhuang T, Gong H, Mi R, Huang Y, Chen Z and Li G: Anti-tumoral
effect and action mechanism of exosomes derived from toxoplasma
gondii-infected dendritic cells in mice colorectal cancer. Front
Oncol. 12:8705282022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ismail CA, Eissa MM, Gaafar MR, Younis LK
and El Skhawy N: Toxoplasma gondii-derived antigen modifies tumor
microenvironment of Ehrlich solid carcinoma murine model and
enhances immunotherapeutic activity of cyclophosphamide. Med Oncol.
40:1362023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eissa MM, Gaafar MR, Younis LK, Ismail CA
and El Skhawy N: Prophylactic antineoplastic activity of Toxoplasma
gondii RH derived antigen against ehrlich solid carcinoma with
evidence of shared antigens by comparative immunoblotting. Infect
Agents Cancer. 18:212023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou LJ, Chen M, Puthiyakunnon S, He C,
Xia J, He CY, Deng SQ and Peng HJ: Toxoplasma gondii ROP18 inhibits
human glioblastoma cell apoptosis through a mitochondrial pathway
by targeting host cell P2X1. Parasit Vectors. 12:2842019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mani R, Martin CG, Balu KE, Wang Q,
Rychahou P, Izumi T, Evers BM and Suzuki Y: A novel protozoa
parasite-derived protein adjuvant is effective in immunization with
cancer cells to activate the cancer-specific protective immunity
and inhibit the cancer growth in a murine model of colorectal
cancer. Cells. 13:1112024. View Article : Google Scholar : PubMed/NCBI
|
